| PDT | photodynamic therapy |
| I-PDT | interstitial photodynamic therapy |
| RPCI | Roswell Park Cancer Institute |
| PS | photosensitizer |
| EB-PDT | external beam PDT |
| SOC | standard of care |
| MLu, Lutex | motexafin lutetium |
| TookadTM | palladium bacteriopheophorbide |
| mTHPC, FoscanTM | meso-tetrahydroxyphenylchlorin |
| 5-ALA | 5-aminolevulinic acid |
| Verteporfin | VisudyneTM |
| 3-D | three-dimensional |
| TRUS | transrectal ultrasound |
| PSA | Prostate Specific Antigen |
| BOLD | blood oxygenation level-dependent |
| MRI | magnetic resonance imaging |
| J | energy |
| J/cm2 | energy density |
| J/cm | linear energy |
| mW/cm2 | intensity |
| FEM | finite elements method |
| iDOSE | Interactive Dosimetry by Sequential Evaluation |
| MC | Monte Carlo |
| CT | computed tomography |
| LAHNC | locally advanced head and neck cancer |
| EMA | European Medicines Agency |